About
SoniVie Ltd. is a medical device company focused on developing and commercializing its proprietary TIVUS™ Ultrasound System for renal denervation, a procedure aimed at treating hypertension. Founded in 2014, the company's technology is based on therapeutic intravascular ultrasound. Their TIVUS system is currently an investigational device undergoing clinical trials, including a global Renal Denervation FDA IDE Pivotal Trial (THRIVE). SoniVie aims to provide a no-touch, deep, and fast renal denervation solution for patients with uncontrolled hypertension. The company has received three Breakthrough Device Designations from the FDA and has two Premarket Applications for FDA approvals.
Performance
Company Timeline
No timeline data for this period
Score Breakdown
13Traction
0Team
0Visibility
10Profile
25Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does SoniVie do?
SoniVie Ltd. is a medical device company focused on developing and commercializing its proprietary TIVUS™ Ultrasound System for renal denervation, a procedure aimed at treating hypertension. Founded in 2014, the company's technology is based on therapeutic intravascular ultrasound. Their TIVUS system is currently an investigational device undergoing clinical trials, including a global Renal Denervation FDA IDE Pivotal Trial (THRIVE). SoniVie aims to provide a no-touch, deep, and fast renal dener…